PHILADELPHIA, Feb. 24, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today that the full text of the Hemispherx presentation given at the National Press Club (NPC) Conference in Washington, DC, on January 30, 2014 is being posted on the corporate website (www.hemispherx.net ). The NPC presentation followed the announcement of new clinical data at the American Society of Microbiology (ASM) Biodefense Conference in Washington, DC, on January 29, 2014. Brief summaries of the clinical results were thereafter published on February 10, 2014 in Drug Discovery News (http://www.ddn-news.com/index.php?newsarticle=8120 ) entitled Hemispherx Biopharma reports progress toward a universal influenza vaccine to prevent pandemic threats and on January 30, 2014 in Science Business Tech News (http://sciencebusiness.technewslit.com/?p=16676 ) entitled Early Trial Finds Vaccine Booster Covers Pandemic Flu Types.
Help employers find you! Check out all the jobs and post your resume.
